7Baggers

Axonics Modulation Technologies Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 -25.15-8.757.6524.0540.4556.8573.2589.65Milllion

Axonics Modulation Technologies Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 
                           
  net revenue116,193,000 114,565,000 91,409,000 109,735,000 93,100,000 92,894,000 70,650,000 85,918,000 70,384,000 68,980,000 48,420,000 53,135,000 46,913,000   34,783,000 35,243,000 15,213,000 26,296,000 9,946,000 1,309,000 1,488,000 1,077,000 494,000 201,000 
  cost of goods sold26,542,000 25,422,000 22,156,000 26,975,000 23,996,000 22,704,000 18,150,000 22,951,000 19,124,000 18,784,000 15,178,000 17,744,000 15,719,000 17,135,000 13,974,000 12,652,000 13,434,000 8,463,000 9,895,000 4,538,000 632,000 772,000 548,000 245,000 106,000 
  gross profit89,651,000 89,143,000 69,253,000 82,760,000 69,104,000 70,190,000 52,500,000 62,967,000 51,260,000 50,196,000 33,242,000 35,391,000 31,194,000 28,734,000 20,399,000 22,131,000 21,809,000 6,750,000 16,401,000 5,408,000 677,000 716,000 529,000 249,000 95,000 
  yoy29.73% 27.00% 31.91% 31.43% 34.81% 39.83% 57.93% 77.92% 64.33% 74.69% 62.96% 59.92% 43.03% 325.69% 24.38% 309.23% 3121.42% 842.74% 3000.38% 2071.89% 612.63%     
  qoq0.57% 28.72% -16.32% 19.76% -1.55% 33.70% -16.62% 22.84% 2.12% 51.00% -6.07% 13.45% 8.56% 40.86% -7.83% 1.48% 223.10% -58.84% 203.27% 698.82% -5.45% 35.35% 112.45% 162.11%  
  gross margin %             62.64% 59.35%           
  operating expenses                         
  research and development13,491,000 12,792,000 11,056,000 9,714,000 8,167,000 8,949,000 8,056,000 8,103,000 7,936,000 7,135,000 11,236,000 10,182,000 8,648,000 9,098,000 9,369,000 8,140,000 7,748,000 6,398,000 6,884,000 6,233,000 4,855,000 4,874,000 4,219,000 4,783,000 3,898,000 
  general and administrative23,761,000 16,327,000 15,104,000 11,095,000 11,778,000 10,713,000 12,168,000 10,264,000 9,389,000 10,572,000 10,013,000 9,404,000 8,720,000 8,035,000 6,626,000 6,588,000 5,773,000 5,537,000 7,653,000 5,537,000 5,162,000 4,362,000 4,015,000 3,501,000 2,790,000 
  sales and marketing52,972,000 51,444,000 56,191,000 55,094,000 47,544,000 44,270,000 42,654,000 43,824,000 39,751,000 39,381,000 33,063,000 31,338,000 28,112,000 25,411,000 20,928,000 18,284,000 17,057,000 14,220,000 16,569,000 16,301,000 15,707,000 10,750,000 5,914,000 1,416,000 949,000 
  amortization of intangible assets2,221,000 2,247,000 2,254,000 2,261,000 2,302,000 2,279,000 2,222,000 2,271,000 2,317,000 2,332,000 2,463,000 2,147,000 2,216,000 2,200,000 678,000           
  acquisition-related costs3,474,000 2,652,000 3,827,000 3,530,000  602,000 1,766,000 2,114,000 8,242,000 12,205,000     4,414,000           
  acquired in-process research & development     15,447,000                    
  total operating expenses95,919,000 85,462,000 88,432,000 81,694,000 69,791,000 82,260,000 66,866,000 66,576,000 67,635,000 71,625,000 56,775,000 53,071,000 47,696,000 44,744,000 42,015,000 33,012,000 30,578,000 26,155,000 31,106,000 28,071,000 25,724,000 19,986,000 14,148,000 9,700,000 7,637,000 
  income from operations-6,268,000 3,681,000 -19,179,000 1,066,000 -687,000 -12,070,000 -14,366,000 -3,609,000 -16,375,000 -21,429,000 -23,533,000 -17,680,000 -16,502,000 -16,010,000 -21,616,000 -10,881,000 -8,769,000 -19,405,000 -14,705,000 -22,663,000 -25,047,000 -19,270,000 -13,619,000 -9,451,000 -7,542,000 
  yoy812.37% -130.50% 33.50% -129.54% -95.80% -43.67% -38.95% -79.59% -0.77% 33.85% 8.87% 62.49% 88.19% -17.50% 47.00% -51.99% -64.99% 0.70% 7.97% 139.79% 232.10%     
  qoq-270.28% -119.19% -1899.16% -255.17% -94.31% -15.98% 298.06% -77.96% -23.58% -8.94% 33.11% 7.14% 3.07% -25.93% 98.66% 24.08% -54.81% 31.96% -35.11% -9.52% 29.98% 41.49% 44.10% 25.31%  
  operating margin %             -34.90% -62.89%           
  other income4,712,000 4,670,000 3,914,000 4,390,000 4,188,000 4,424,000 4,311,000 3,752,000 -397,000 -479,000 -246,000 27,000 -220,000 -5,842,000 -1,442,000 -467,000 -399,000 -378,000 90,000 -88,000 41,000 210,000 502,000 234,000 -196,000 
  interest and other income4,704,000 4,702,000 3,973,000 4,541,000 4,271,000 4,250,000 3,628,000 8,159,000 -1,898,000 -839,000 -289,000 102,000 -229,000 -5,849,000 -1,450,000 -445,000 -434,000 -443,000 -552,000 -562,000 -586,000 -629,000 -532,000   
  income before income tax (benefit) expense-1,556,000       143,000 -16,772,000 -21,908,000     -23,058,000           
  income tax (benefit) expense-1,535,000       -522,000 -520,000 -465,000     -555,000           
  net income-21,000 6,899,000 -19,112,000 6,574,000 3,928,000 -7,342,000 -9,248,000 665,000 -16,252,000 -21,443,000 -22,668,000 -15,166,000 -17,250,000 -25,148,000 -22,503,000 -11,348,000 -9,168,000 -19,783,000 -14,616,000 -22,751,000 -25,006,000 -19,061,000 -13,117,000 -9,665,000 -7,566,000 
  yoy-100.53% -193.97% 106.66% 888.57% -124.17% -65.76% -59.20% -104.38% -5.79% -14.73% 0.73% 33.64% 88.15% 27.12% 53.96% -50.12% -63.34% 3.79% 11.43% 135.40% 230.50%     
  qoq-100.30% -136.10% -390.72% 67.36% -153.50% -20.61% -1490.68% -104.09% -24.21% -5.40% 49.47% -12.08% -31.41% 11.75% 98.30% 23.78% -53.66% 35.35% -35.76% -9.02% 31.19% 45.32% 35.72% 27.74%  
  net income margin %             -54.83% -65.47%           
  foreign currency translation adjustment10,438,000 466,000 -1,152,000 8,644,000 -6,185,000 3,750,000 3,071,000 11,038,000 -12,057,000 -12,648,000 -4,920,000 352,000 -5,138,000 859,000 -2,202,000 183,000 99,000 -108,000 -177,000 153,000 -112,000 -43,000 -10,000 -10,000 -1,000 
  comprehensive income10,417,000 7,365,000                        
  net income per share0.14 -0.38 0.14 0.08 -0.15 -0.19 0.03 -0.34 -0.47 -0.5 -0.33 -0.38 -0.59 -0.57 -0.28 -0.24 -0.54 -0.43 -0.75 -0.89 -0.68 -0.47 3.46 -2.67 
  weighted-average shares used for eps calculation51,088,073 50,010,380 50,928,171 49,081,470 49,244,981 49,088,373 48,579,084 46,684,478 47,208,192 45,311,001 45,139,038 43,072,298 44,848,023 42,788,678 39,613,964 36,981,335 38,830,924 36,440,846 33,637,646 28,567,302 28,098,564 27,945,393 27,828,201 6,997,777 2,830,591 
  income before income tax benefit 8,351,000 -15,265,000 -3,550,000 3,501,000 -7,646,000 -10,055,000    -23,779,000               
  income tax benefit 1,452,000 3,847,000 -384,500 -427,000 -304,000 -807,000    -1,111,000               
  comprehensive loss  -20,264,000 -3,006,500 -2,257,000 -3,592,000 -6,177,000 11,703,000 -28,309,000 -34,091,000 -27,588,000 -14,814,000 -22,388,000 -24,289,000 -24,705,000 -11,165,000 -9,069,000 -19,891,000 -14,793,000 -22,598,000 -25,118,000 -19,104,000 -13,127,000 -9,675,000 -7,567,000 
  interest income       476,000 1,501,000 360,000 43,000 16,000 9,000 7,000 8,000 19,000 35,000 65,000 642,000 474,000 627,000 839,000 1,034,000 550,000 172,000 
  income before income tax expense           -17,653,000 -16,722,000 -21,852,000  -11,348,000 -9,168,000 -19,783,000 -14,615,000 -22,751,000 -25,006,000 -19,060,000 -13,117,000 -9,665,000 -7,566,000 
  income tax expense           -2,487,000 528,000 3,296,000     1,000   1,000    
  sacral neuromodulation net revenue             40,194,000 32,903,000           
  bulkamid net revenue             5,675,000 1,470,000           
  total net revenue             45,869,000 34,373,000           
  yoy                         
  qoq             33.44%            

We provide you with 20 years income statements for Axonics Modulation Technologies stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Axonics Modulation Technologies stock. Explore the full financial landscape of Axonics Modulation Technologies stock with our expertly curated income statements.

The information provided in this report about Axonics Modulation Technologies stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.